PSA cut point of more than 0.4 ng/mL predicts progression

PSA cut point of ≥0.4 ng/mL predicts progression

(HealthDay)—A prostate-specific antigen cut point of ≥0.4 ng/mL predicts future disease progression, according to a study published in the June issue of The Journal of Urology.

Amir Toussi, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues reviewed long-term prostatectomy outcomes to examine the most appropriate cut point that predicts subsequent disease progression. Data were included for 13,512 patients with cT1-2N0M0 prostate cancer who underwent .

The researchers found that a detectable prostate-specific antigen developed in 5,041 patients at a median postoperative follow-up of 9.1 years, and systemic progression developed in 512 patients. The percentage of experiencing a continued prostate-specific antigen increase over five years was 61, 67, and 74 percent, respectively, after reaching the prostate-specific antigen cut point of 0.2, 0.3, and 0.4 ng/mL, plateauing at 0.4 ng/mL. The strongest correlation between biochemical recurrence and systemic progression was seen for a single prostate-specific antigen cut point of 0.4 ng/mL or more.

"A prostate-specific antigen cut point of 0.4 ng/mL or greater reflects the threshold at which a prostate-specific antigen increase becomes durable and shows the strongest correlation with subsequent systemic progression," the authors write.


Explore further

Many low-risk prostate cancer cases upgraded at prostatectomy

More information: Abstract
Full Text
Editorial (subscription or payment may be required)
Journal information: Journal of Urology

Copyright © 2016 HealthDay. All rights reserved.

Citation: PSA cut point of more than 0.4 ng/mL predicts progression (2016, June 20) retrieved 14 November 2019 from https://medicalxpress.com/news/2016-06-psa-ngml.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments